Are you or someone you know considering coming off Lexapro (escitalopram) or Celexa (citalopram)? Many people aren't adequately informed about how to safely discontinue these medications, leading to unnecessary withdrawal symptoms and suffering. In this educational webinar, Dr. Mark Horowitz, MD, PhD, clinical research fellow at University College London and Scientific Co-Founder of Outro Health, shares cutting-edge research and practical strategies for safely tapering these commonly prescribed SSRIs. What You'll Learn: - Why even "mild" SSRIs like Lexapro and Celexa can cause severe withdrawal symptoms for some patients - The critical role of serotonin transporter occupancy and dose-response curves in tapering success - Hyperbolic tapering protocols specifically tailored to escitalopram and citalopram - Clinical and lifestyle factors that can support smoother discontinuation How Outro's virtual care model supports safe, personalized tapering plans This presentation includes insights from Emma Frati, who brings valuable lived experience with polypharmacy along with her background in Behavioral Neuroscience. Who This Is For: This comprehensive webinar benefits clinicians, patients, caregivers, and anyone interested in understanding evidence-based approaches to antidepressant deprescribing. About Outro Health: Outro is a virtual care platform specializing in safe, evidence-based antidepressant tapering. Our team of trained clinicians provides personalized hyperbolic tapering plans, regular check-ins, and ongoing support throughout the discontinuation process. Learn more about our services at You can follow Outro on other social channels to stay up to date about more webinars. Instagram - Facebook - X (Twitter) - #mentalhealth #antidepressants #ssritapering #lexapro #celexa #mentalhealthawareness #medicaleducation #patientcare #healthylifestyle #wellnessjourney #webinar #medicalseminar #healthtalk #patienteducation #evidencebasedmedicine #psychotherapy #psychiatry #ssri #mentalwellness #antidepressantwithdrawal #AntidepressantWithdrawal #EvidenceBasedMedicine #DeprescribingAwareness #MentalHealthEducation #OutroHealth #DrMarkHorowitz #UCLResearch #escitalopram #citalopram #medicationsafety #mentalhealthsupport #deprescribing #safetapering #psychiatricmedication #discontinuationsyndrome #serotonin #brainhealth #patientsafety #prescribingpractices #hyperbolicreduction